Atlas Trials

Intrathecal Dexmedetomidine to Decrease Postoperative Nausea and Vomiting and Shivering.

Clinical trial NCT05892705 · COMPLETED

Trial details

NCT number
NCT05892705
Sponsor
Ain Shams University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Intrathecal Dexmedetomidine
Start date
2021-06-01
Primary completion
2023-01-15
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.